Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001209191-20-060968

EVP, Research & CSO sold 2,930 shares at $30.00 ($87,900)

  • EVP, Research & CSO acquired 2,930 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Virgin Herbert EVP, Research & CSO 2020-11-27 Option exercise +2,930 $1.53 $4,483 26,630 D
Virgin Herbert EVP, Research & CSO 2020-11-27 Sale −2,930 $30.00 $87,900 23,700 D
Derivatives
Virgin Herbert EVP, Research & CSO 2020-11-27 Option exercise · Stock Option (Right to Buy) −2,930 442,900 D
Open-market sales · 2,930 sh · avg $30.00 · $87,900
Loading xslF345X03/doc4.xml…